Kymera Therapeutics

Kymera Therapeutics Announces Leadership Transitions

Nello Mainolfi Named President of the Company Bruce Jacobs Appointed Chief Financial Officer Cambridge, Mass. (July 15, 2019) – Kymera Therapeutics Inc., a biotechnology company advancing the field of targeted protein degradation to create breakthrough therapies for previously untreatable diseases,